Voronoi, Signed Contract for Technology Transfer in Targeted Therapy Research and Development
[Asia Economy Reporter Lee Jung-yoon] Voronoi announced on the 22nd that it has signed a technology licensing agreement with Voronoi Bio for the research and development of a new targeted therapy.
Hot Picks Today
!["Despite Complaints About Sweat, She Straps On a 15kg Bag and Pushes Through the Deadly Heatwave [Sociology of Heatwaves] ①"](https://cwcontent.asiae.co.kr/asiaresize/93/2026081215431278523_1786516992.gif)
"Despite Complaints About Sweat, She Straps On a 15kg Bag and Pushes Through the Deadly Heatwave [Sociology of Heatwaves] ①"
- "We’ll Refund or Resume Trips in Two Years"...Youth Travel Agency Suddenly Halts Operations, Consumers Panic
- "Warnings Are Over"... 100,000 Won Fines for Drinking and Smoking at Cheonggyecheon Amid Rising Disorder
- Chairperson Jungin Cha: "No Need for Private Institutes if Written and Essay Exams Are Introduced... Extensive Reading Is Enough"
- "Controversy Over Female YouTuber Who Filmed in Mixed-Gender Bath Despite Knowing Filming Was Prohibited"
The company stated, "The technology involves a targeted therapy candidate substance aimed at mutations in EGFR non-small cell lung cancer," adding, "It is planned to be developed as an oral drug with higher mutation selectivity and brain permeability compared to competing substances."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
